Published Technical Disclosure Archive

Integrated Soft Tissue Defect Reconstruction System

Publication ID: 24-11857403_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Integrated Soft Tissue Defect Reconstruction System,” Published Technical Disclosure No. 24-11857403_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857403_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,403.

Summary of the Inventive Concept

The integrated system combines a segmented skirted surgical mesh with AI, IoT, blockchain, and novel materials to revolutionize soft tissue defect reconstruction, providing real-time monitoring, personalized design, and decentralized data management.

Background and Problem Solved

The original segmented skirted surgical mesh patent addressed the need for a reliable and effective solution for soft tissue defect reconstruction. However, it lacked real-time monitoring capabilities, personalized design options, and secure data management. The new inventive concept solves these limitations by integrating the surgical mesh with cutting-edge technologies.

Detailed Description of the Inventive Concept

The integrated system comprises a segmented skirted surgical mesh, an AI-powered sensor for monitoring tissue healing and mesh integration, an IoT-enabled tracking device for real-time mesh performance tracking, and a blockchain-based patient data management system. The system enables personalized surgical mesh design using machine learning algorithms and 3D printing. Additionally, the mesh can be infused with novel antimicrobial materials for enhanced tissue integration. The decentralized blockchain network ensures secure and transparent data management.

Novelty and Inventive Step

The integration of AI, IoT, blockchain, and novel materials with the segmented skirted surgical mesh is new and non-obvious, providing a synergistic combination that revolutionizes soft tissue defect reconstruction. The use of machine learning algorithms for personalized design and decentralized blockchain networks for data management are particularly innovative.

Alternative Embodiments and Variations

Alternative embodiments include using different AI algorithms, IoT devices, or blockchain platforms. Variations of the system could include integrating additional sensors, using different materials for the mesh, or incorporating other technologies like robotics or virtual reality.

Potential Commercial Applications and Market

The integrated soft tissue defect reconstruction system has significant commercial potential in the medical device industry, particularly in the areas of hernia repair, tissue engineering, and personalized medicine. Target markets include hospitals, medical research institutions, and pharmaceutical companies.

CPC Classifications

SectionClassGroup
A A61 A61F2/0063

Field of Art

Medical device engineering, specifically surgical mesh design and soft tissue reconstruction technologies, requiring advanced knowledge of biomaterials, medical device integration, and surgical repair techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in surgical implant design, materials science, sensor integration, and advanced manufacturing techniques, holding at least a master's degree with 3-5 years of specialized experience

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with surgical mesh represents a predictable extension of existing medical device innovation. The core segmented surgical mesh structure remains fundamentally unchanged, while added technologies like AI monitoring and blockchain tracking represent incremental improvements using known interdisciplinary techniques. The combination of mechanical design principles from the source patent with emerging digital health technologies would be an obvious approach for enhancing surgical mesh functionality and patient outcomes.

Obvious Combinations & Variations

Source Patent Element
Segmented skirted surgical mesh base layer with specific geometric configurations
PTD Variation
3D printing customized mesh geometries using machine learning patient data analysis
Obviousness Reasoning
Personalized medical device design is a known technique, and adapting mesh geometry based on patient-specific data represents a predictable application of existing design optimization methods
Source Patent Element
Surgical mesh for soft tissue reconstruction
PTD Variation
Integrating IoT-enabled tracking sensors for real-time mesh performance monitoring
Obviousness Reasoning
Embedding sensors in medical implants is a well-established technique, and monitoring device performance represents a logical extension of existing medical technology development approaches
Source Patent Element
Surgical mesh base material
PTD Variation
Infusing mesh with novel antimicrobial materials
Obviousness Reasoning
Material enhancement through functional additives is a standard approach in biomaterials engineering, with predictable goals of improving implant performance and reducing infection risks
Source Patent Element
Surgical mesh for soft tissue repair
PTD Variation
Blockchain-based decentralized patient data management system
Obviousness Reasoning
Secure medical data management using distributed technologies is an emerging but predictable solution in healthcare informatics, representing an obvious technological progression
Source Patent Element
Surgical mesh with segmented configuration
PTD Variation
AI-powered sensor integration for tissue healing monitoring
Obviousness Reasoning
Applying machine learning and sensor technologies to medical device performance tracking represents a natural technological evolution with predictable implementation strategies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857403 and the comprehensive technical disclosure, a person of ordinary skill in the art would find the proposed variations obvious and lacking inventive step. The incremental technological enhancements, including AI monitoring, IoT tracking, blockchain management, and personalized design techniques, represent predictable applications of known interdisciplinary medical device engineering principles, thereby rendering potential claims obvious under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,403
TitleSegmented skirted surgical mesh